Many couples faced with infertility are treated with ovulation inducing medicines. Recently,
concerns have been raised about the possible risk of ovarian malignancy after such ovarian …

Objective To review studies that have examined the epidemiology and etiology of the
development of epithelial carcinoma of the ovary. Data Identification Important published …

As long as doubt persists, it might be advisable to reflect on a few clinical recommendations:
identify high-risk infertile patients for ovarian cancer, investigate preexisting cancer before …

Conclusions It should be noted that citing problems with epidemiologic studies is not the
same as disproving their claims. However, it does cast doubt upon the validity and general …

The possible link between ovulation-inducing agents and ovarian cancer has been the focus
of considerable research effort over the past decade. Epidemiological studies addressing …

Introduction Ovarian cancer is a significant health concern worldwide and is the leading
cause of death from gynecologic malignancies. While fertility preservation is essential for …

Objective To review critically the published data regarding the proposed association of
ovulation induction, infertility, and an increased risk of ovarian cancer. Design A medline …

OBJECTIVE: To critically examine the possible association between ovulation-inducing
drugs and ovarian cancer. DESIGN: Medline literature review and cross-reference of …

OBJECTIVE: To assess the long-term effects of ovulation-stimulating drugs on the risk of
ovarian cancer. METHODS: A retrospective cohort study of 12,193 eligible study subjects …

Recently, much attention in both the medical and lay communities has been focused on a
possible association between fertility drug use and invasive ovarian cancer, and ovarian …